MAPLE GROVE, Minn. – Upsher-Smith Laboratories announced that Taku Nakaoka has been appointed chairman and chief executive officer (CEO) of Upsher-Smith, effective May 13. Additionally, senior vice president of Corporate Strategy, Rich Fisher, has been appointed president and chief operating officer (COO) responsible for the day-to-day leadership of Upsher-Smith. Nakaoka succeeds Rusty Field, who previously
CHARLOTTE, N.C. — Upsher-Smith Laboratories announced that Ira Katz, owner of Little Five Points Pharmacy in Atlanta, is the winner of the National Community Pharmacists Association 2021 Willard B. Simmons Independent Pharmacist of the Year Award. Katz received the award on Monday, Oct. 11 at NCPA’s 123rd Annual Convention in Charlotte, N.C. The annual award
MAPLE GROVE, Minn. — Last week, Upsher-Smith Laboratories offered a free on-site COVID-19 vaccination clinic at no cost to all employees and their spouses and will offer a similar second clinic four weeks later in accordance with the prescribed timing of the Moderna vaccine. The clinic is the result of a partnership between Upsher-Smith and
MAPLE GROVE, Minn. — Upsher-Smith Laboratories and the National Alliance of State Pharmacy Associations (NASPA) are honoring the 2020 NASPA Excellence in Innovation Award recipients. Forty-two pharmacists from across the nation were recognized for their outstanding contributions to the profession of pharmacy. The annual award is coordinated by NASPA and sponsored by Upsher-Smith. “Upsher-Smith is pleased to continue
MAPLE GROVE, Minn. — Kenneth L. Evenstad, founder of Upsher-Smith Laboratories and co-founder of Domaine Serene Vineyards & Winery, died at his home in Oregon, Oct. 21, 2020, having fought chronic pulmonary issues for the past five years. He was 77 years of age. Evenstad was born July 9, 1943 in Baudette, Minn., a tiny
MAPLE GROVE, Minn. — Upsher-Smith Laboratories and the National Alliance of State Pharmacy Associations (NASPA) have honored 44 pharmacists from across the United States with the 2019 NASPA Excellence in Innovation Award for their outstanding contributions to the profession of pharmacy. The annual award sponsored by Upsher-Smith is given by NASPA and state pharmacy associations. The
MAPLE GROVE, Minn. — Upsher-Smith Laboratories announced the launch of Vigadrone (vigabatrin) for Oral Solution, 500 mg, a fully substitutable, AA-rated generic version of Sabril (vigabatrin) powder for oral solution. The product was approved by the U.S. Food and Drug Administration (FDA) on June 21, 2018. The Vigabatrin powder market had U.S. sales of approximately $333 million for the 12 months
MAPLE GROVE, Minn. — Upsher-Smith Laboratories, LLC (Upsher-Smith) announced the launch of Doxazosin tablets, USP, 1 mg, 2 mg, 4 mg and 8 mg. The product was approved by the U.S. Food and Drug Administration (FDA) on April 17, 2018. Upsher-Smith’s Doxazosin tablets are an AB-rated generic version of the branded product, Cardura (doxazosin mesylate
MAPLE GROVE, Minn. — Upsher-Smith Laboratories LLC said its Japan-based parent, Sawai Pharmaceutical Co., has agreed to sell a 20% stake in its Sawai America Inc. subsidiary to Sumitomo Corp. of Americas (SCOA). Under the deal, SCOA — part of global conglomerate Sumitomo Corp. — is slated to buy the interest in Sawai America for $211
MAPLE GROVE, Minn. — Upsher-Smith Laboratories LLC has launched an enhanced website for its Qudexy XR anti-epileptic and migraine medication. Upsher-Smith said Monday that QudexyXR.com features the company’s Access Pathways Program aimed at reducing the barriers associated with prescribing Qudexy XR (topiramate). QudexyXR.com also offers health care providers tools necessary to help their patients “Start,
PHOENIX — The Healthcare Distribution Alliance (HDA) this week presented its annual Distribution Industry Awards for Notable Achievements in Healthcare (DIANA) to pharmaceutical manufacturers for supply chain innovation and collaboration. Given at the HDA 2017 Business and Leadership Conference in Phoenix, the DIANA awards honor HDA member manufacturers that develop innovative new products and promotions
TOKYO and MINNEAPOLIS — Sawai Pharmaceutical Co. Ltd. has closed its $1.05 billion acquisition of the Upsher-Smith Laboratories generic drug business. Sawai, which unveiled the deal with Upsher-Smith parent Acova Inc. in April, plans to retain Upsher’s headquarters in Minnesota and operation in Colorado. And as previously announced, Upsher-Smith will retain its current leadership, with
MAPLE GROVE, Minn — Upsher-Smith Laboratories Inc. has launched clomipramine hydrochloride capsules, an antidepressant, in the United States. Upsher-Smith said its clomipramine hydrochloride comes in dosages of 25 mg, 50 mg and 75 mg in 100-count bottles and is a generic version of Anafranil capsules from Mallinckrodt Pharmaceuticals. A tricyclic antidepressant, Anafranil is indicated for
MAPLE GROVE, Minn. — Upsher-Smith Laboratories Inc. and the National Alliance of State Pharmacy Associations (NASPA) have recognized the efforts 43 pharmacists from across the nation with the 2016 NASPA Excellence in Innovation Award. Upsher-Smith said Wednesday that the pharmacists were honored for their outstanding contributions to the pharmacy profession. Sponsored by Upsher-Smith, the award is
